Skip Navigation
Polsinelli's logo
  • Our People
  • Our Capabilities
  • Our Firm
    • About Us
    • Alumni Network
    • Careers
    • Insights
      • News
      • Events
      • Publications
      • Blogs & Podcasts
    • Offices & Locations
    • Our Diverse Culture
Photo of undefined undefined
Photo of undefined undefined

Zachary M. Seelenfreund

Associate
zseelenfreund@polsinelli.com
Download Bio
New York: 212.803.9949
  • Biography
  • News

News

August 01, 2025 Deals & Cases
Polsinelli Represents Saphyre in Securing $70 Million Investment from FTV Capital
March 05, 2025 Deals & Cases
Polsinelli Advises Fifth Ocean in Blue Monkey Beverages Investment
November 22, 2024 Deals & Cases
Polsinelli Represents NWO.ai in its Acquisition by Growth Protocol
June 08, 2023 Deals & Cases
Polsinelli Advises Australian Marketing Technology Company North Star in Sale to International Customer Engagement Platform Braze
Firm Highlights
Slide 1 of 6
  • Event
    Polsinelli Pulse Series: Shelf Space – Strategies for Dominating the CPG Marketplace
    Join Polsinelli as we speak with investors in, and founders of, your favorite CPG brands, to learn what they’ve done right, what they’ve done wrong, and what they’re still trying to figure out.
    Read more
  • News
    Polsinelli Secures Dismissal of Data Breach Class Action for Delta Health
    Polsinelli recently secured a significant win for firm client Delta County Memorial Hospital District (Delta Health), obtaining dismissal of a putative data breach class action in the District Court for Delta County, Colorado.
    Read more
  • Blog
    Where Identity Meets Precedent: The EEOC Addresses Bathroom and Locker Room Access Under Title VII
    Read more
  • News
    Polsinelli Advises Americana Partners on Acquisition of NRT Consulting
    Polsinelli recently represented Americana Partners (Americana), a Houston-based wealth management firm, in its acquisition of NRT Consulting, a bespoke and full-service financial consulting and accounting firm.
    Read more
  • Publication
    Not Joking Around: FDA Offers Additional Clarification on Compounded GLP-1 Policy in April Fool’s Day Announcement
    FDA's April 1, 2026, update to its compounding policy page follows more than 18 months of regulatory activity surrounding the compounding of GLP-1 medications.
    Read more
  • Publication
    The Politics of AI Regulation: Federal Government v. the States
    On December 11, 2025, President Trump signed Executive Order 14365, “Ensuring a National Policy Framework for Artificial Intelligence.” 
    Read more
Follow us on LinkedInFollow us on Instagram
© 2026 Polsinelli. Attorney Advertising.
Prior results do not guarantee a similar outcome.
Contact UsSubscribeAlumni NetworkCollaborate PolsinelliClient Payment PortalDisclaimerCookie PreferencesPrivacy Notice